Stay updated with breaking news from Glenmark Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Glenmark Pharma soared as management's bullish FY25 targets offset weak quarterly earnings. Despite widening losses due to impairment charges, adjusted net profit nearly tripled, driven by a stake sale in Glenmark Life Sciences.
Glenmark Pharmaceuticals optimistic about growth trajectory, divesting stake in Glenmark Life Sciences, and focusing on global brands.
Buy Glenmark Life Sciences shares for a target of Rs 900 with a stop loss at Rs 800 Buy NHPC shares for a target of Rs 107 with a stop loss at Rs 94
Glenmark Life Sciences Q4 Results Live : Revenue decreased by 13.64% YoY & profit decreased by 33.08% YoY
Stocks to watch: Shares of firms like Axis Bank, HUL, TechM, Nestle, Bajaj Finance, RVNL, ITC, and others will be in focus on Thursday's trade.